The New Era of Genetic Testing – Color

“Genetic testing has entered a new era and our older paradigms are no longer sufficient.” That’s the context for a new study in the journal Oncology, “What’s New in Genetic Testing for Cancer Susceptibility?” While covering a range of issues, the article identifies opportunities and challenges that genetic testing is bringing to the clinic as it becomes more affordable, available, and instrumental in an expanding number of areas of medicine. Below are some of the key points that underscore the authors’ conclusion: it is imperative we “find every mutation carrier for every hereditary syndrome before the disease occurs,” to enable preventative screening or treatment. This is an important part of the promise of precision medicine.

Want to get a deeper dive? Here’s the full article.